<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="case-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Diagn Pathol</journal-id>
<journal-id journal-id-type="iso-abbrev">Diagn Pathol</journal-id>
<journal-title-group>
<journal-title>Diagnostic Pathology</journal-title>
</journal-title-group>
<issn pub-type="epub">1746-1596</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31684969</article-id>
<article-id pub-id-type="pmc">6829978</article-id>
<article-id pub-id-type="publisher-id">902</article-id>
<article-id pub-id-type="doi">10.1186/s13000-019-0902-5</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Clinical, genetic, and molecular characterization of hyperphosphatasia with mental retardation: a case report and literature review</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Abi Farraj</surname>
<given-names>Layal</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Khatoun</surname>
<given-names>Wassim Daoud</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Abou Chebel</surname>
<given-names>Naji</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wakim</surname>
<given-names>Victor</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dawali</surname>
<given-names>Katia</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2107-9929</contrib-id>
<name>
<surname>Ghassibe-Sabbagh</surname>
<given-names>Michella</given-names>
</name>
<address>
<email>michella.sabbagh@lau.edu.lb</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2324 5973</institution-id><institution-id institution-id-type="GRID">grid.411323.6</institution-id><institution>Department of Natural Sciences, School of Arts and Sciences, </institution><institution>Lebanese American University, </institution></institution-wrap>Beirut, Lebanon </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2324 5973</institution-id><institution-id institution-id-type="GRID">grid.411323.6</institution-id><institution>School of Medicine, </institution><institution>Lebanese American University, </institution></institution-wrap>Beirut, Lebanon </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>4</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>4</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>14</volume>
<elocation-id>123</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>8</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>10</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2019</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p id="Par1">Hyperphosphatasia with mental retardation syndrome (HPMRS) is a recessive disorder characterized by high blood levels of alkaline phosphatase together with typical dysmorphic signs such as cleft palate, intellectual disability, cardiac abnormalities, and developmental delay. Genes involved in the glycosylphosphatidylinositol pathway and known to be mutated in HPMRS have never been characterized in the Lebanese population.</p>
</sec>
<sec>
<title>Case presentation</title>
<p id="Par2">Herein, we describe a pair of monozygotic twins presenting with severe intellectual disability, distinct facial dysmorphism, developmental delay, and increased alkaline phosphatase level. Two individuals underwent whole exome sequencing followed by Sanger sequencing to confirm the co-segregation of the mutation in the consanguineous family. A biallelic loss of function mutation in <italic>PGAP3</italic> was detected. Both patients were homozygous for the c.203delC (p.C68LfsX88) mutation and the parents were carriers confirming the founder effect of the mutation. High ALP serum levels confirmed the molecular diagnosis.</p>
</sec>
<sec>
<title>Conclusion</title>
<p id="Par3">Our findings have illustrated the genomic profile of <italic>PGAP3</italic>-related HPMRS which is essential for targeted molecular and genetic testing. Moreover, we found previously unreported clinical findings such as hypodontia and skin hyperpigmentation. These features, together with the novel mutation expand the phenotypic and genotypic spectrum of this rare recessive disorder.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Cleft palate</kwd>
<kwd>
<italic>PGAP3</italic>
</kwd>
<kwd>Lebanese population</kwd>
<kwd>Syndromic</kwd>
<kwd>HPMRS</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution>Lebanese American University, School Research and Development Council (SRDC)</institution>
</funding-source>
<award-id>NA</award-id>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p id="Par12">Orofacial clefts (OFCs) are the most common congenital craniofacial birth defects [<xref ref-type="bibr" rid="CR10">10</xref>]. Their prevalence varies widely between populations with an average of 1/700 live births [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. OFCs arise as a result of genetic and environmental factors interfering abnormally with a set of coordinated events leading to the development of the craniofacial processes between the 4th and 8th gestational weeks [<xref ref-type="bibr" rid="CR6">6</xref>]. According to genetic and epidemiological risk factors, OFCs have been divided into cleft lip with or without the palate (CL/P) and cleft palate only (CPO) [<xref ref-type="bibr" rid="CR9">9</xref>]. Clefts are known for their complex etiology and lifelong morbidity [<xref ref-type="bibr" rid="CR9">9</xref>]. OFCs are mainly nonsyndromic (70% of CL/P and 50% of CPO) [<xref ref-type="bibr" rid="CR9">9</xref>]. A large number of the genetic factors involved in the remaining 30% syndromic clefts has been identified through the advancement of the genetic screening techniques [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Hyperphosphatasia with mental retardation syndrome (HPMRS) (OMIM # 239300) was first described in 1970, and was later designated as Mabry Syndrome [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Typical facial dysmorphic signs such as cleft palate, intellectual disability, cardiac abnormalities, and brachytelephalangy are frequently described in affected individuals [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Elevated serum levels of alkaline phosphatase (ALP) have been recorded in several patients [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR8">8</xref>].</p>
<p id="Par13">Characterizing mutations underlying diseases with Mendelian patterns of inheritance by using exome sequencing is a powerful approach to explain the etiology of the disease. As part of a study of the genetic basis of different syndromic cleft phenotypes in the Lebanese population, we report the results of exome sequencing of four individuals from the same family. Our data shows novel variants in the previously established causative gene, <italic>PGAP3</italic> (OMIM #611801): a new phenotypic relationship with HPMRS.</p>
</sec>
<sec id="Sec2">
<title>Case presentation</title>
<sec id="Sec3">
<title>Data collection</title>
<p id="Par14">Since establishing the craniomaxillofacial research project at the Lebanese American University, we have examined over 100 patients with orofacial dysmorphic features, including a pair of twins suffering from a severe developmental syndrome. Participants provided written informed consent prior to filling out the questionnaire or giving blood samples. Parents of the minor participants provided a written declaration of consent as they were legally authorized representatives. Research and data collection were carried out in compliance with the Helsinki Declaration, with the approval of the LAU Institutional Review Board and the Committee on Human Subjects in Research (CHSR). De-identified data about the neurological, muscular, epithelial, and connective tissues related development was collected and all medical problems were obtained from medical charts.</p>
<p id="Par15">ALP levels were measured in all patients. Information including brain imaging, EEG, skin biopsies, echocardiograms, and thyroid profile were also performed. Parents were examined and genomic DNA was extracted from peripheral blood of the patients and their two parents using the standard phenol-chloroform extraction procedure.</p>
</sec>
<sec id="Sec4">
<title>Genetic analysis</title>
<p id="Par16">Whole exome enrichment was performed on genomic DNA using the SureSelect Human All Exon V6 (Agilent). Whole exome sequencing was performed on an Illumina Hi-Seq 3000 platform using a 150 bp paired-end protocol with an average depth of 60x. Reads were aligned against the human assembly GRCh37 using Burrows-Wheeler Aligner (BWA). Data analysis was performed using SAMtools [<xref ref-type="bibr" rid="CR16">16</xref>], Picard [<xref ref-type="bibr" rid="CR5">5</xref>], the Genome Analysis Toolkit (GATK) [<xref ref-type="bibr" rid="CR18">18</xref>] and Variant Effect Predictor (VEP). Polymorphisms were removed by reference to their population frequencies by searching for such mutations in genetic disease databases including OMIM (<ext-link ext-link-type="uri" xlink:href="http://omim.org">http://omim.org</ext-link>), HGMD (<ext-link ext-link-type="uri" xlink:href="http://www.hgmd.cf.ac.uk/ac/index.php">http://www.hgmd.cf.ac.uk/ac/index.php</ext-link>), ClinVar (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/clinvar">https:www.ncbi.nlm.nih.gov/clinvar</ext-link>), the database of the 1000 Genomes Project (<ext-link ext-link-type="uri" xlink:href="http://www.1000genomes.org/">http://www.1000genomes.org/</ext-link>), ESP6500 (<ext-link ext-link-type="uri" xlink:href="http://evs.gs.washington.edu/EVS/">http://evs.gs.washington.edu/EVS/</ext-link>), and ExAC (<ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/">http://exac.broadinstitute.org</ext-link>). The effects of mutations on protein function were predicted with the aid of PolyPhen 2 (<ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2/">http://genetics.bwh.harvard.edu/pph2/</ext-link>), SIFT (<ext-link ext-link-type="uri" xlink:href="http://sift.jcvi.org/">http://sift.jcvi.org</ext-link>), and CADD (<ext-link ext-link-type="uri" xlink:href="https://cadd.gs.washington.edu/">https://cadd.gs.washington.edu/</ext-link>). The prioritization of genes was conducted using Pubmatrix (<ext-link ext-link-type="uri" xlink:href="https://pubmatrix.irp.nia.nih.gov/">https://pubmatrix.irp.nia.nih.gov/</ext-link>) followed by further assessment in relation to clinical characteristics.</p>
</sec>
<sec id="Sec5">
<title>Clinical characteristics</title>
<p id="Par17">There was a first-degree consanguinity between the parents of the twin pair (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). No family history of HPMRS was recorded and both parents reported to be young and healthy at the time of conception. The twins were nine-year-old at the time of data collection. They presented hypotonia with a lack of voluntary coordination of muscle movements prohibiting them from walking, absence of speech, and abnormalities in the eye movement with down-slanting eyelids. They both suffered from growth retardation and epilepsy. No signs of autism or hyperactivity were recorded. Head magnetic resonance imaging showed evidence of 2 × 2 cm area of bleed in the left temporal lobe of both affected individuals with the presence of an abnormal vein. No arterial abnormality was seen. The pattern of gyration and myelination was normal as well as the ventricles. Skin biopsy following the description of skin hyperpigmentation confirmed the diagnosis of incontinentia pigmenti, although the WES data did not show any mutation in <italic>IKBKG</italic>, previously reported to be linked to the condition [<xref ref-type="bibr" rid="CR25">25</xref>]. The twins had typical facial features with a wide nasal bridge, tent-shaped lips, and a cleft of the anterior and posterior palate together with typical recurrent ear infections. Gastroscopy in one of the twins, 4CF1, showed the presence of marked esophagitis, large hiatal hernia, petechial gastritis, and minimal nodular duodenitis. In the other twin, 5CF1, cardiac ultrasonography showed a congenital ventricular septal defect with the presence of a heart murmur. He also presented a clinodactyly of the fifth digit (Fig. <xref ref-type="fig" rid="Fig1">1</xref> and Table <xref ref-type="table" rid="Tab1">1</xref>).
<fig id="Fig1"><label>Fig. 1</label><caption><p>Pedigree of family. Filled symbols, affected; <inline-graphic id="d29e478" xlink:href="13000_2019_902_Figa_HTML.gif"></inline-graphic> , consanguinity;<inline-graphic id="d29e481" xlink:href="13000_2019_902_Figb_HTML.gif"></inline-graphic>, monozygotic twins</p></caption><graphic id="MO1" xlink:href="13000_2019_902_Fig1_HTML"></graphic></fig>
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Summary of the Clinical data comparing previously reported cases of <italic>PAPG3</italic> with our two current cases</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Clinical Data</th><th>Current case report</th><th>Previous Cases Reported (26) [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]</th></tr></thead><tbody><tr><td>Consanguinity</td><td>2/2</td><td>16/26</td></tr><tr><td>Cleft Palate</td><td>2/2</td><td>17/26</td></tr><tr><td>Postnatal Microcephaly</td><td>2/2</td><td>8/26</td></tr><tr><td>Short Stature</td><td>2/2</td><td>2/26</td></tr><tr><td>Seizures</td><td>2/2</td><td>17/26</td></tr><tr><td>Coarse Facies</td><td>2/2</td><td>26/26</td></tr><tr><td>Developmental Delay</td><td>2/2</td><td>26/26</td></tr><tr><td>Speech Delay</td><td>2/2</td><td>26/26</td></tr><tr><td>High ALP level (relative to age)</td><td>2/2</td><td>26/26</td></tr><tr><td>Hyperactive &amp; Autistic Behavior</td><td>2/2</td><td>14/26</td></tr><tr><td>Congenital Heart Defects</td><td>1/2</td><td>2/26</td></tr><tr><td>
<bold>Clinodactyly</bold>
</td><td>2/2</td><td>0/26</td></tr><tr><td>Small teeth</td><td>0/2</td><td>1/26</td></tr><tr><td>
<bold>Hypodontia</bold>
</td><td>2/2</td><td>0/26</td></tr><tr><td>
<bold>Hyperpigmentation(Incontinentia Pigmenti)</bold>
</td><td>2/2</td><td>0/26</td></tr></tbody></table><table-wrap-foot><p>In bold font are the new clinical features that were not previously reported in any case of the mutation</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec6">
<title>Mutational analysis</title>
<p id="Par18">The analysis of the whole exome data showed that the patient 5CF1 carried a homozygous frameshift mutation in <italic>PGAP3</italic>, exon 2, c.203delC (p.C68LfsX88) (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). The father (2CF1) was heterozygous for the same mutation. Sanger sequencing was used to confirm the mutation in the two above-studied individuals, and to look for its presence in the mother (3CF1) as well as the other twin (4CF1). Results showed that both parents were carriers for the mutation, and both children were homozygous for the mutation. The presence of an A &gt; G substitution in intron 2, 110 base pairs 3′ of the c.203delC change (genomic position 39,685,888 bp), excluded the hemizygous mutation hypothesis. Although the cytosine on the position 203 has previously been shown to be substituted, the current deletion has not been reported previously in any population. No other relevant nucleotide changes were found. In order to confirm the presence of the HPMRS syndrome, a dosage of the level of ALP was done. The results showed that the ALP level was of 390 U/L and 327 U/L for 4CF1 and 5CF1 respectively.</p>
</sec>
<sec id="Sec7">
<title>Structural analysis</title>
<p id="Par19">The mutation resulted in a stop codon replacing a cysteine residue at the 68th amino acid position. Thus, the corresponding protein has only 67 amino acids, compared to 320 amino acids in the wild type protein. Phyre2 suggested the 320 amino-acid normal protein to present seven transmembrane alpha helices spanning amino acids 99 to 296 [<xref ref-type="bibr" rid="CR13">13</xref>]. However, since the mutated protein has only the first 67 amino acids, no transmembrane helices in this protein were suggested by Phyre2 [<xref ref-type="bibr" rid="CR13">13</xref>]. This indicates that the protein is no longer capable of getting integrated in the membrane of Golgi apparatus, as the literature states [<xref ref-type="bibr" rid="CR22">22</xref>]. The templates to which both the normal and the mutated proteins were aligned in the Phyre2 software further support this hypothesis (Fig. <xref ref-type="fig" rid="Fig2">2</xref>).
<fig id="Fig2"><label>Fig. 2</label><caption><p>Right panel, amino acid sequence followed by secondary structure prediction. Green helices represent α-helices, and faint lines indicate coil. The line below helices indicates the confidence in the prediction, with red being high confidence and blue low confidence. The yellow helices indicate a weak prediction. Left panel, The homology modeled structure of the PGAP3 protein depicted from the Phyre2 result in cartoon format. <bold>a</bold>, wild-type protein; <bold>b</bold>, mutated protein</p></caption><graphic id="MO2" xlink:href="13000_2019_902_Fig2_HTML"></graphic></fig></p>
</sec>
</sec>
<sec id="Sec8">
<title>Discussion and conclusions</title>
<p id="Par20">In the 2001 version of the London Dysmorphology Database, 487 monogenic syndromes have been reported to be associated with ORFs [<xref ref-type="bibr" rid="CR7">7</xref>]. As part of the effort of studying the genetic basis of Lebanese families presenting syndromic clefts, we were able to identify a novel <italic>PGAP3</italic>, “post-GPI attachment top 3”, mutation in one consanguineous family. The latter mutation suggested that the family presented a hyperphosphatasia with mental retardation syndrome, falling under the monogenic syndrome categorization. In order to confirm that the dysmorphic features encountered in the family are part of the HPMRS syndrome, a dosage of the level of ALP was done. The elevated levels of ALP in the blood confirmed the molecular diagnosis in the family. Interestingly, the level of ALP is 1.03 and 1.24 higher than the normal ALP range for boys between 7 and 9 years (86–315 U/L).</p>
<p id="Par21"><italic>PGAP3</italic> encodes a glycosylphosphatidylinositol (GPI)-specific phospholipase that removes unsaturated fatty acids from GPI anchored protein in the Golgi apparatus where it primarily localizes and performs the first step of fatty acid remodeling [<xref ref-type="bibr" rid="CR22">22</xref>]. The GPI-anchored proteins (GPI-APs) and lipid rafts proper association is mainly due to the remodeling of the constituent fatty acids on GPI. The symptoms caused by <italic>PGAP3</italic> mutations could be caused by the inability of the GPI-APs in cells to localize on lipid rafts because of their non-remodeled lipid structure, despite the presence of normal levels of PGAP3 in the cells [<xref ref-type="bibr" rid="CR14">14</xref>].</p>
<p id="Par22">To date, only 16 pathogenic <italic>PGAP3</italic> mutations have been identified in patients with HPMRS [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. Ten out of the 16 mutations are in exon 3 and exon 7 which are considered hotspots for mutations. The majority of these mutations are missense mutations; however, frameshift, splice site, and 3’UTR mutations were reported. The mutation reported in this case report raises the number of mutations to 17 mutations. It is a homozygous frameshift mutation located in exon 2, c.203delC (p.C68LfsX88), affecting monozygotic twins resulting from a consanguineous marriage.</p>
<p id="Par23">The monozygotic twins have features concordant with an HPMRS phenotype although they showed the most severe spectrum of the phenotype. In addition to signs already associated with HPMRS, they also showed clinodactyly, hypodontia, as well as hyperpigmentation, a phenotype that has never been reported in HPMRS caused by a <italic>PGAP3</italic> mutation (Table <xref ref-type="table" rid="Tab1">1</xref>).</p>
<p id="Par24">In summary, we reported a novel homozygous mutation in <italic>PGAP3</italic> in a consanguineous Lebanese cleft syndromic family associated with hyperphosphatasia with mental retardation syndrome. Novel features not reported as part of this syndrome before were present. This case report shows that ORFs associated with global developmental delay and facial dysmorphism with elevated alkaline phosphatase are important clues for HPMRS. In addition, it shows that whole exome sequencing helps increase the diagnostic yield for heterogeneous conditions such as syndromic ORFs encountered more commonly in consanguineous families. Molecular diagnosis might enable a proper recognition of the associated syndromes and anomalies with ORFs by finding the causative agents, which is essential for informative genetic counselling, prenatal diagnosis, targeted treatment and prevention in case it is possible.</p>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>ALP</term>
<def>
<p id="Par4">Alkaline phosphatase</p>
</def>
</def-item>
<def-item>
<term>CHSR</term>
<def>
<p id="Par5">Committee on Human Subjects in Research</p>
</def>
</def-item>
<def-item>
<term>CPO</term>
<def>
<p id="Par6">Cleft palate only</p>
</def>
</def-item>
<def-item>
<term>GPI</term>
<def>
<p id="Par7">Glycosylphosphatidylinositol</p>
</def>
</def-item>
<def-item>
<term>GPI-Aps</term>
<def>
<p id="Par8">GPI-anchored proteins</p>
</def>
</def-item>
<def-item>
<term>HPMRS</term>
<def>
<p id="Par9">Hyperphosphatasia with mental retardation syndrome</p>
</def>
</def-item>
<def-item>
<term>OFCs</term>
<def>
<p id="Par10">Orofacial clefts</p>
</def>
</def-item>
<def-item>
<term>WES</term>
<def>
<p id="Par11">Whole Exome Sequencing</p>
</def>
</def-item>
</def-list>
</glossary>
<fn-group>
<fn>
<p>
<bold>Publisher’s Note</bold>
</p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
</fn-group>
<ack>
<title>Acknowledgements</title>
<p>The authors are grateful to the patients for their participation in the study.</p>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>LAF did the whole exome sequencing and analysis. WDK did the protein remodeling analysis. NAC contributed to the diagnoses and data collection. VW assisted in patient selection and table preparation. KD did the Sanger sequencing. MGS guided the whole study, drafted, and revised the manuscript. All authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="funding-information">
<title>Funding</title>
<p>This study was partially funded by the Lebanese American University, School Research and Development Council (SRDC), Research Grant: “Genetic Determinants of Craniofacial Anomalies”.</p>
</notes>
<notes notes-type="data-availability">
<title>Availability of data and materials</title>
<p>The datasets generated and/or analyzed in this case report are available from the corresponding author upon reasonable request.</p>
</notes>
<notes>
<title>Ethics approval and consent to participate</title>
<p id="Par25">The study was approved by the LAU Institutional Review Board and the Committee on Human Subjects in Research (CHSR) (approval no. LAU.SAS.MS1.23). Informed consent was obtained from participants. All experiments were carried out in accordance with relevant guidelines and regulations.</p>
</notes>
<notes>
<title>Consent for publication</title>
<p id="Par26">Not applicable.</p>
</notes>
<notes notes-type="COI-statement">
<title>Competing interests</title>
<p id="Par27">The authors declare that they have no competing interests.</p>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdel-Hamid</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Issa</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Otaify</surname>
<given-names>GA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PGAP3-related hyperphosphatasia with mental retardation syndrome: report of 10 new patients and a homozygous founder mutation</article-title>
<source/>Clin Genet
          <year>2018</year>
<volume>93</volume>
<issue>1</issue>
<fpage>84</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="doi">10.1111/cge.13033</pub-id>
<pub-id pub-id-type="pmid">28390064</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abouelhoda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sobahy</surname>
<given-names>T</given-names>
</name>
<name>
<surname>El-Kalioby</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical genomics can facilitate countrywide estimation of autosomal recessive disease burden</article-title>
<source/>Genet Med
          <year>2016</year>
<volume>18</volume>
<issue>12</issue>
<fpage>1244</fpage>
<lpage>1249</lpage>
<pub-id pub-id-type="doi">10.1038/gim.2016.37</pub-id>
<pub-id pub-id-type="pmid">27124789</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Basha</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Demeer</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Revencu</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Whole exome sequencing identifies mutations in 10% of patients with familial non-syndromic cleft lip and/or palate in genes mutated in well-known syndromes</article-title>
<source/>J Med Genet
          <year>2018</year>
<volume>55</volume>
<issue>7</issue>
<fpage>449</fpage>
<lpage>458</lpage>
<pub-id pub-id-type="doi">10.1136/jmedgenet-2017-105110</pub-id>
<pub-id pub-id-type="pmid">29500247</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cole</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>MD</given-names>
</name>
</person-group>
<article-title>Neurogenetic Aspects of Hyperphosphatasia in Mabry Syndrome</article-title>
<source/>Subcell Biochem
          <year>2015</year>
<volume>76</volume>
<fpage>343</fpage>
<lpage>361</lpage>
<pub-id pub-id-type="doi">10.1007/978-94-017-7197-9_16</pub-id>
<pub-id pub-id-type="pmid">26219719</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DePristo</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Banks</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Poplin</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A framework for variation discovery and genotyping using next-generation DNA sequencing data</article-title>
<source/>Nat Genet
          <year>2011</year>
<volume>43</volume>
<issue>5</issue>
<fpage>491</fpage>
<lpage>498</lpage>
<pub-id pub-id-type="doi">10.1038/ng.806</pub-id>
<pub-id pub-id-type="pmid">21478889</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferguson</surname>
<given-names>MW</given-names>
</name>
</person-group>
<article-title>Palate development</article-title>
<source/>Development
          <year>1988</year>
<volume>103</volume>
<fpage>41</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="pmid">3074914</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<mixed-citation publication-type="other">Fryns JP, de Ravel TJ. London Dysmorphology Database, London Neurogenetics Database and Dysmorphology Photo Library on CD-ROM [Version 3] 2001R. M. Winter, M. Baraitser, Oxford University Press, ISBN 019851–780, pound sterling 1595. Hum Genet. 2002;111(1):113.</mixed-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Mutations in the PIGW gene associated with hyperphosphatasia and mental retardation syndrome: a case report</article-title>
<source/>BMC Pediatr
          <year>2019</year>
<volume>19</volume>
<issue>1</issue>
<fpage>68</fpage>
<pub-id pub-id-type="doi">10.1186/s12887-019-1440-8</pub-id>
<pub-id pub-id-type="pmid">30813920</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghassibe-Sabbagh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Desmyter</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Langenberg</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>FAF1, a gene that is disrupted in cleft palate and has conserved function in zebrafish</article-title>
<source/>Am J Hum Genet
          <year>2011</year>
<volume>88</volume>
<issue>2</issue>
<fpage>150</fpage>
<lpage>161</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2011.01.003</pub-id>
<pub-id pub-id-type="pmid">21295280</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghassibe</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bayet</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Revencu</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Orofacial clefting: update on the role of genetics</article-title>
<source/>B-ENT
          <year>2006</year>
<volume>2</volume>
<issue>Suppl 4</issue>
<fpage>20</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="pmid">17366841</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horn</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Schottmann</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Meinecke</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Hyperphosphatasia with mental retardation, brachytelephalangy, and a distinct facial gestalt: delineation of a recognizable syndrome</article-title>
<source/>Eur J Med Genet
          <year>2010</year>
<volume>53</volume>
<issue>2</issue>
<fpage>85</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejmg.2010.01.002</pub-id>
<pub-id pub-id-type="pmid">20080219</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howard</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Murakami</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Pagnamenta</surname>
<given-names>AT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in PGAP3 impair GPI-anchor maturation, causing a subtype of hyperphosphatasia with mental retardation</article-title>
<source/>Am J Hum Genet
          <year>2014</year>
<volume>94</volume>
<issue>2</issue>
<fpage>278</fpage>
<lpage>287</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2013.12.012</pub-id>
<pub-id pub-id-type="pmid">24439110</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelley</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Mezulis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yates</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Wass</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>Sternberg</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>The Phyre2 web portal for protein modeling, prediction and analysis</article-title>
<source/>Nat Protoc
          <year>2015</year>
<volume>10</volume>
<issue>6</issue>
<fpage>845</fpage>
<lpage>858</lpage>
<pub-id pub-id-type="doi">10.1038/nprot.2015.053</pub-id>
<pub-id pub-id-type="pmid">25950237</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knaus</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Awaya</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Helbig</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rare noncoding mutations extend the mutational Spectrum in the PGAP3 subtype of Hyperphosphatasia with mental retardation syndrome</article-title>
<source/>Hum Mutat
          <year>2016</year>
<volume>37</volume>
<issue>8</issue>
<fpage>737</fpage>
<lpage>744</lpage>
<pub-id pub-id-type="doi">10.1002/humu.23006</pub-id>
<pub-id pub-id-type="pmid">27120253</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krawitz</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Schweiger</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Rodelsperger</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome</article-title>
<source/>Nat Genet
          <year>2010</year>
<volume>42</volume>
<issue>10</issue>
<fpage>827</fpage>
<lpage>829</lpage>
<pub-id pub-id-type="doi">10.1038/ng.653</pub-id>
<pub-id pub-id-type="pmid">20802478</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Handsaker</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wysoker</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The sequence alignment/map format and SAMtools</article-title>
<source/>Bioinformatics.
          <year>2009</year>
<volume>25</volume>
<issue>16</issue>
<fpage>2078</fpage>
<lpage>2079</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id>
<pub-id pub-id-type="pmid">19505943</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mabry</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Bautista</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kirk</surname>
<given-names>RF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Familial hyperphosphatase with mental retardation, seizures, and neurologic deficits</article-title>
<source/>J Pediatr
          <year>1970</year>
<volume>77</volume>
<issue>1</issue>
<fpage>74</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="doi">10.1016/S0022-3476(70)80047-6</pub-id>
<pub-id pub-id-type="pmid">5465362</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKenna</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hanna</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Banks</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data</article-title>
<source/>Genome Res
          <year>2010</year>
<volume>20</volume>
<issue>9</issue>
<fpage>1297</fpage>
<lpage>1303</lpage>
<pub-id pub-id-type="doi">10.1101/gr.107524.110</pub-id>
<pub-id pub-id-type="pmid">20644199</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mossey</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Little</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Munger</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Dixon</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>WC</given-names>
</name>
</person-group>
<article-title>Cleft lip and palate</article-title>
<source/>Lancet.
          <year>2009</year>
<volume>374</volume>
<issue>9703</issue>
<fpage>1773</fpage>
<lpage>1785</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(09)60695-4</pub-id>
<pub-id pub-id-type="pmid">19747722</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nampoothiri</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hebbar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>AG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Hyperphosphatasia with mental retardation syndrome due to a novel mutation in PGAP3</article-title>
<source/>J Pediatr Genet
          <year>2017</year>
<volume>6</volume>
<issue>3</issue>
<fpage>191</fpage>
<lpage>193</lpage>
<pub-id pub-id-type="doi">10.1055/s-0037-1599148</pub-id>
<pub-id pub-id-type="pmid">28794914</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pagnamenta</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Murakami</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>JM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Analysis of exome data for 4293 trios suggests GPI-anchor biogenesis defects are a rare cause of developmental disorders</article-title>
<source/>Eur J Hum Genet
          <year>2017</year>
<volume>25</volume>
<issue>6</issue>
<fpage>669</fpage>
<lpage>679</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2017.32</pub-id>
<pub-id pub-id-type="pmid">28327575</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pei</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Millay</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Olson</surname>
<given-names>EN</given-names>
</name>
<name>
<surname>Grishin</surname>
<given-names>NV</given-names>
</name>
</person-group>
<article-title>CREST--a large and diverse superfamily of putative transmembrane hydrolases</article-title>
<source/>Biol Direct
          <year>2011</year>
<volume>6</volume>
<fpage>37</fpage>
<pub-id pub-id-type="doi">10.1186/1745-6150-6-37</pub-id>
<pub-id pub-id-type="pmid">21733186</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pengelly</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Upstill-Goddard</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Arias</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Resolving clinical diagnoses for syndromic cleft lip and/or palate phenotypes using whole-exome sequencing</article-title>
<source/>Clin Genet
          <year>2015</year>
<volume>88</volume>
<issue>5</issue>
<fpage>441</fpage>
<lpage>449</lpage>
<pub-id pub-id-type="doi">10.1111/cge.12547</pub-id>
<pub-id pub-id-type="pmid">25441681</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakaguchi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zigman</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Petkovic Ramadza</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A novel PGAP3 mutation in a Croatian boy with brachytelephalangy and a thin corpus callosum</article-title>
<source/>Hum Genome Var
          <year>2018</year>
<volume>5</volume>
<fpage>18005</fpage>
<pub-id pub-id-type="doi">10.1038/hgv.2018.5</pub-id>
<pub-id pub-id-type="pmid">29531774</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swinney</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Karth</surname>
<given-names>PA</given-names>
</name>
</person-group>
<article-title>Incontinentia Pigmenti: a comprehensive review and update</article-title>
<source/>Ophthalmic Surg Lasers Imaging Retina
          <year>2015</year>
<volume>46</volume>
<issue>6</issue>
<fpage>650</fpage>
<lpage>657</lpage>
<pub-id pub-id-type="doi">10.3928/23258160-20150610-09</pub-id>
<pub-id pub-id-type="pmid">26114846</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yavarna</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Al-Dewik</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Al-Mureikhi</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High diagnostic yield of clinical exome sequencing in middle eastern patients with Mendelian disorders</article-title>
<source/>Hum Genet
          <year>2015</year>
<volume>134</volume>
<issue>9</issue>
<fpage>967</fpage>
<lpage>980</lpage>
<pub-id pub-id-type="doi">10.1007/s00439-015-1575-0</pub-id>
<pub-id pub-id-type="pmid">26077850</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>